Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pietro Forte
Observed name:
Pietro, Forte
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0009-0000-5759-1911
Observed ORCID:
0009-0000-5759-1911
OpenAlex ID:
A5124030682
SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under Hyperglycemia
2026
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Sodium–glucose cotransporter 2 inhibitors in breast cancer patients on endocrine therapy: a targeted strategy to mitigate long-term cardiometabolic risk
2026
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
Journal of Translational Medicine
·
1
Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in Patients With Cancer
2026
·
Vincenzo Quagliariello
, Margherita Passariello
, et al.
·
Journal of Cardiovascular Pharmacology
·
1
Effect of GLP-1 receptor agonism on anthracycline- and HER2-targeted therapy–induced cardiac dysfunction and systemic inflammation in non-diabetic preclinical models.
2026
·
Vincenzo Quagliariello
, Annabella Di Mauro
, et al.
·
Journal of Clinical Oncology
Effects of SGLT2 inhibitor dapagliflozin on anticancer resistance and alpelisib- and fulvestrant-induced cardiomyocyte injury under hyperglycemic conditions.
2026
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
Journal of Clinical Oncology
Heart-Type Fatty Acid-Binding Protein (H-FABP) as a Candidate Adjunctive Biomarker for Immune Checkpoint Inhibitor-Related Cardiotoxicity: Linking Early Immune–Metabolic Myocardial Injury with Translational Cardio-Oncology
2026
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
International Journal of Molecular Sciences
26-A-8401-ACC SACUBITRIL-VALSARTAN REDUCES H-FABP, HS-CTNT, HS-CRP AND MONOCYTE-TO-LYMPHOCYTE RATIO IN ANTHRACYCLINE-TREATED PRECLINICAL MODELS THROUGH INHIBITION OF NLRP3/IL1β SIGNALING
2026
·
Nicola Maurea
, Annabella Di Mauro
, et al.
·
Journal of the American College of Cardiology
26-a-8322-acc Pcsk9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure Via Nlrp3 and Myd88 Pathway Inhibition
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
26-a-8402-acc Metabolic Modulation by Sglt2 Inhibitors Canagliflozin and Dapagliflozin: a Novel Strategy to Balance Antitumor Efficacy and Cardiotoxicity in Her2-positive Breast Cancer Therapy
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
26-a-8399-acc Nlrp3 Selective Antagonist Reduces Anthracycline+/-trastuzumab Induced Cardiotoxicity Through Inhibition of Ferroptosis and Activation of Pampk Pathways in Hipsc-cms Cells
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
Show more works
View as search
Works count:
11
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type